• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Varian ups market forecast

Article

Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26%

Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26% growth for the quarter. The better-than-expected earnings reflect a recovery much stronger than was anticipated in the x-ray products business, according to Varian. The company is also reporting continued strength in its oncology business. The strong quarter puts annual company earnings per diluted share for fiscal 2003 on track to grow by 29% to 31% over fiscal 2002 totals.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.